Related references
Note: Only part of the references are listed.Hyperthermia and Multiorgan Failure After Abuse of Bath Salts Containing 3,4-Methylenedioxypyrovalerone
Heather A. Borek et al.
ANNALS OF EMERGENCY MEDICINE (2012)
Designer drugs: a medicinal chemistry perspective
F. Ivy Carroll et al.
ADDICTION REVIEWS (2012)
Interaction of mephedrone with dopamine and serotonin targets in rats
Jose Martinez-Clemente et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Analysis of First and Second Generation Legal Highs for Synthetic Cannabinoids and Synthetic Stimulants by Ultra-Performance Liquid Chromatography and Time of Flight Mass Spectrometry
Kevin G. Shanks et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2012)
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats
Adam L. Halberstadt et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Death Following Recreational Use of Designer Drug Bath Salts Containing 3,4-Methylenedioxypyrovalerone (MDPV)
Brittany L. Murray et al.
JOURNAL OF MEDICAL TOXICOLOGY (2012)
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats
J. Kehr et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Clinical toxicology of newer recreational drugs
Simon L. Hill et al.
CLINICAL TOXICOLOGY (2011)
Clinical experience with and analytical confirmation of bath salts and legal highs (synthetic cathinones) in the United States
Henry A. Spiller et al.
CLINICAL TOXICOLOGY (2011)
Methylone and Monoamine Transporters: Correlation with Toxicity
Chiharu Sogawa et al.
CURRENT NEUROPHARMACOLOGY (2011)
Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease
Cameron H. Good et al.
FASEB JOURNAL (2011)
In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat
Michael H. Baumann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Bath Salts Intoxication
Edward A. Ross et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse
Gregory C. Hadlock et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines
Sonja Sucic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The reverse operation of Na+/Cl--coupled neurotransmitter transporters - why amphetamines take two to tango
Harald H. Sitte et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Brain biomarkers for identifying excited delirium as a cause of sudden death
Deborah C. Mash et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil
Dorota Zolkowska et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector
Yuan-Hao Chen et al.
FASEB JOURNAL (2008)
Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices
Carrie E. John et al.
NEUROPHARMACOLOGY (2007)
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain
Fumiko Nagai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
Michael H. Baumann et al.
PSYCHOPHARMACOLOGY (2007)
1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors
PC Meltzer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs
S Wee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Monoamine transporters and psychostimulant drugs
RB Rothman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates
RB Rothman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Effects of dopamine agonists and antagonists on locomotor activity in male and female rats
CW Schindler et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Firing modes of midbrain dopamine cells in the freely moving rat
BI Hyland et al.
NEUROSCIENCE (2002)
Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D-1/D-2 agonists
S Ikemoto
NEUROSCIENCE (2002)
Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes
AT Corera et al.
NEUROSCIENCE RESEARCH (2001)